The in vivo effect of tiger nut/black seed oil on sickle cell patients
Research type
Research Study
Full title
An investigation into cellular oxidative stress and ROS in sickle cell anaemia patients and its reversal with a range of natural and novel antioxidants.
IRAS ID
229870
Contact name
Yvonne Elliott
Sponsor organisation
Coventry University
Duration of Study in the UK
0 years, 2 months, 27 days
Research summary
How effective are tiger nut oil and black seed oil as antioxidant sickle cell treatments, when consumed regularly by sickle cell patients?
Sickle cell anaemia (SCA) is a genetically inherited red blood cell disorder, whereby normal spherical erythrocytes (red blood cells) become sickle shaped, due to a genetic mutation in the haemoglobin-beta gene. The sickle blood cells are also more adhesive to blood vessel endothelium. This leads to disrupted blood flow and reduced oxygen transport; symptomatically this results in vaso-occlusive crises, episodes of joint pain in varying severity and frequency. A contributing factor to erythrocyte sickling is increased generation of reactive oxygen species (ROS), particularly free radicals, in combination with decreased natural antioxidant capacity in SCA subjects. Antioxidants are required to scavenge excessive free radicals as they have the potential to cause cellular damage.Tiger nut oil (Cyperus esculentus) and black seed oil (Nigella sativa) have been anecdotally passed down through generations of SCA families living in regions of Nigeria. This research will focus on the antioxidant ability of these oils in relation to their efficacy as potential SCA treatments/dietary supplements, when tested on SCA patients from Coventry hospital. Consenting participants will be required to complete questionnaires and have blood samples taken at specific time points during the study, as well as consuming either tiger nut oil or black seed oil (subjects will be randomly assigned) on a daily basis for a set period of time (~3 months).
A benefit of novel natural SCA treatments is the reduced dependence on prescribed drugs such as hydroxyurea, which carry risks of side effects including iron overload. It is also possible that antioxidant supplements will reduce the frequency of required blood transfusions, which are invasive and time consuming. Overall, these treatments aim to improve quality of life for SCA patients.
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
17/WM/0450
Date of REC Opinion
27 Dec 2017
REC opinion
Unfavourable Opinion